Related Experiment Video
Updated: Jun 18, 2026
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
Ceftaroline versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in an
Sinan Mermer1, Tuncer Turhan2, Elif Bolat2
1Cine State Hospital, Aydin, Turkey; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Bornova, Izmir, Turkey.
Objectives:
The aim of this study was to compare the antibacterial activity of ceftaroline versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) meningitis in an experimental rabbit meningitis model.
Methods:
The antibacterial activity of ceftaroline was compared with vancomycin in the treatment of meningitis induced by MRSA strain ATCC 43300 in an experimental rabbit meningitis model. Quantitative cerebrospinal fluid (CSF) cultures were performed at the beginning of antibiotic treatment and 24h and 73h after the first antibiotic dose. Furthermore, in vitro time-kill data were investigated at 0, 2, 4, 6, 8, 12 and 24h in sterile human serum.
Results:
The difference between the control group versus both treatment groups was significant when comparing the decrease in colony counts in CSF both at 24h and 73h after the first antibiotic dose (P<0.05). At the end of the experiment, there was a significant difference in survival between both the ceftaroline-treated group and the vancomycin-treated group versus the control group, but not between the two treatment groups.
Conclusion:
These results suggest that the antibacterial activity of both ceftaroline and vancomycin are similar in the treatment of MRSA meningitis in an experimental rabbit meningitis model.
Insights
Ceftaroline and vancomycin show similar antibacterial activity for treating methicillin-resistant Staphylococcus aureus (MRSA) meningitis in rabbits. Both antibiotics significantly reduced bacterial counts and improved survival compared to controls.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Bacterial meningitis remains a significant cause of morbidity and mortality.
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a particular challenge due to its resistance to many antibiotics.
- Effective treatment strategies for MRSA meningitis are crucial.
Purpose of the Study:
- To compare the efficacy of ceftaroline and vancomycin in treating MRSA meningitis.
- To evaluate the antibacterial activity of these antibiotics in a preclinical rabbit model.
Main Methods:
- An experimental rabbit meningitis model was used, induced by MRSA strain ATCC 43300.
- Cerebrospinal fluid (CSF) bacterial cultures were quantified at baseline, 24 hours, and 73 hours post-treatment.
- In vitro time-kill assays were conducted in human serum.
Main Results:
- Both ceftaroline and vancomycin treatments led to significant reductions in CSF bacterial colony counts at 24 and 73 hours compared to the control group (P<0.05).
- Survival rates were significantly higher in both antibiotic-treated groups compared to the control group.
- No significant difference in efficacy was observed between ceftaroline and vancomycin treatments.
Conclusions:
- Ceftaroline and vancomycin exhibit comparable antibacterial activity in the treatment of MRSA meningitis.
- These findings support the potential of both agents in managing MRSA meningitis, warranting further clinical investigation.
Related Concept Videos
01:25Mechanism of Antibiotic Resistance in MRSA
01:25Clinical Significance of Antibiotic Resistance